Pyxis Oncology, Inc. (PYXS)
1.64
-0.05
(-2.96%)
USD |
NASDAQ |
Nov 03, 15:16
Pyxis Oncology Net Income (Quarterly) : -25.35M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -25.35M |
| March 31, 2026 | -23.27M |
| December 31, 2025 | -18.11M |
| September 30, 2025 | -22.00M |
| June 30, 2025 | -18.35M |
| March 31, 2025 | -21.16M |
| December 31, 2024 | -35.57M |
| September 30, 2024 | -21.20M |
| June 30, 2024 | -17.30M |
| March 31, 2024 | -3.256M |
| December 31, 2023 | -15.60M |
| Date | Value |
|---|---|
| September 30, 2023 | -23.05M |
| June 30, 2023 | -15.90M |
| March 31, 2023 | -19.24M |
| December 31, 2022 | -36.10M |
| September 30, 2022 | -27.67M |
| June 30, 2022 | -25.56M |
| March 31, 2022 | -31.38M |
| December 31, 2021 | -16.83M |
| September 30, 2021 | -14.18M |
| December 31, 2020 | -4.579M |
| September 30, 2020 | -3.191M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cypherpunk Technologies, Inc. | 39.39M |
| Cue Biopharma, Inc. | -153.07M |
| Yarrow Bioscience, Inc. | -2.899M |
| Faeth Therapeutics, Inc. | -16.01M |
| Indaptus Therapeutics, Inc. | -1.795M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 25.35M |
| EPS Diluted (Quarterly) | -0.3961 |
| Enterprise Value | 90.57M |
| Earnings Yield | -85.57% |
| Normalized Earnings Yield | -85.57 |